PT  - JOURNAL ARTICLE
ED  - ,
TI  - Dental adverse effects of sublingual buprenorphine and naloxone
AID  - 10.1136/dtb.2023.000034
DP  - 2023 Aug 01
TA  - Drug and Therapeutics Bulletin
PG  - 115--115
VI  - 61
IP  - 8
4099  - http://dtb.bmj.com/content/61/8/115.short
4100  - http://dtb.bmj.com/content/61/8/115.full
SO  - Drug Ther Bull2023 Aug 01; 61
AB  - Overview of: Etminan M, Rezaeianzadeh R, Kezouh A, et al. Association between sublingual buprenorphine-naloxone exposure and dental disease. JAMA. 2022;328:2269-71.